Polymedix planned to license the international Brilacidin for ABSSI and retain the US rights because distribution would be easier as it is hospital based. No idea if that is part of the current plan but, I like the idea.
Cog, what a great observation. I completely forgot about that. Keep up the good work! The human element may have turned positive on this board. Go CTIX!!!!!